The Ozempic Flip-Flop
They rationed their remaining supplies, stretching the weekly injections to 10 days, two weeks, even three weeks. They ...
Hims & Hers: Look At What Matters Most
Hims & Hers Health, Inc. has shown significant improvement in key unit economics, positioning it among top-tier SaaS ...
Future Market Insights2h
Anorexiant Market Set to Reach USD 1,883 Million by 2034 with a 5.1% of CAGR
The anorexiant market is expected to grow from USD 1,145 million in 2024 to USD 1,883 million by 2034, at a CAGR of 5.1%.
Science News23h
The benefits of Ozempic and its kin may extend far beyond weight loss
Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.
psychiatryadvisor.com3h
Glucagon Like Peptide 1 Receptor Treatment Linked to Reduced Alcohol Consumption
Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.
Noom Offers Oral Medications For Weight Loss Starting at $29
A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...
Kiromic BioPharma Reports 32% Decrease in Tumor Volume Eight Months Post-Treatment in Fourth Patient Enrolled in Deltacel-01
Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports favorable ongoing efficacy results from the ...